IL-22 and IL-22-Binding Protein Are Associated With Development of and Mortality From Acute-on-Chronic Liver Failure.
Journal
Hepatology communications
ISSN: 2471-254X
Titre abrégé: Hepatol Commun
Pays: United States
ID NLM: 101695860
Informations de publication
Date de publication:
Mar 2019
Mar 2019
Historique:
received:
28
06
2018
accepted:
26
11
2018
entrez:
13
3
2019
pubmed:
13
3
2019
medline:
13
3
2019
Statut:
epublish
Résumé
Interleukin-22 (IL-22) has context-dependent hepatoprotective or adverse properties
Identifiants
pubmed: 30859151
doi: 10.1002/hep4.1303
pii: HEP41303
pmc: PMC6396350
doi:
Types de publication
Journal Article
Langues
eng
Pagination
392-405Références
J Immunol. 2001 Jun 15;166(12):7096-103
pubmed: 11390454
Am J Gastroenterol. 2001 Jul;96(7):1968-76
pubmed: 11467622
Proc Natl Acad Sci U S A. 2001 Aug 14;98(17):9511-6
pubmed: 11481447
Hepatology. 2003 Jul;38(1):258-66
pubmed: 12830009
Hepatology. 2004 May;39(5):1332-42
pubmed: 15122762
Nature. 2007 Feb 8;445(7128):648-51
pubmed: 17187052
Nature. 2009 Feb 5;457(7230):722-5
pubmed: 18978771
Semin Immunopathol. 2010 Mar;32(1):17-31
pubmed: 20127093
Hepatology. 2010 Oct;52(4):1291-300
pubmed: 20842630
Gastroenterology. 2012 Jul;143(1):188-98.e7
pubmed: 22484119
BMC Med. 2012 Sep 11;10:102
pubmed: 22967278
Nature. 2012 Nov 8;491(7423):259-63
pubmed: 23075849
Gastroenterology. 2013 Jun;144(7):1426-37, 1437.e1-9
pubmed: 23474284
Hepatology. 2014 Apr;59(4):1331-42
pubmed: 24677193
J Immunol. 2014 Jun 15;192(12):6037-44
pubmed: 24821973
Annu Rev Immunol. 2015;33:747-85
pubmed: 25706098
Cell Mol Immunol. 2016 May;13(3):301-15
pubmed: 26685902
Hepatology. 2016 Oct;64(4):1249-64
pubmed: 27483394
Science. 2016 Oct 21;354(6310):358-362
pubmed: 27846573
Am J Physiol Cell Physiol. 2017 Sep 1;313(3):C305-C313
pubmed: 28637673
Gut. 2018 Oct;67(10):1870-1880
pubmed: 28847867
Liver Int. 2018 Apr;38(4):645-653
pubmed: 28853199
Hepatology. 2018 Mar;67(3):1027-1040
pubmed: 29023933
J Immunol. 2017 Dec 15;199(12):4078-4090
pubmed: 29109123